Optum Rx is planning to add up to three biosimilar drugs to its formulary to compete directly with AbbVie's Humira, which accounts for massive pharmacy spend each year.
https://www.fiercehealthcare.com/pa...similars-formulary-tackle-massive-cost-humira
https://www.fiercehealthcare.com/pa...similars-formulary-tackle-massive-cost-humira